Skip to main page content

Dr. Isabelle Brunette, MD, FRCSC

2023 Planning Committee - Ocular Regenerative Medicine
Uczestniczy w 6 elementy
After completion of a clinical and research training in ophthalmology (Université de Montréal), corneal transplantation and corneal endothelium (Mayo Clinic, Rochester, MN), and refractive surgery (Emory Eye Clinic, Atlanta, GA), Dr. Brunette started her practice in 1990 as an ophthalmologist at Hôpital Maisonneuve-Rosemont (HMR), Montréal.

Dr. Brunette is full professor in the Department of Ophthalmology of the Université de Montréal. She is head of the Cornea Service at the HMR Department of Ophthalmology, head of Vision Health Research at the HMR Research Centre, and director of the Fonds de recherche du Québec – Santé’s Research in Vision Network. She has successively been member, vice-chair, and chair of the Institute Advisory Board for the Institute of Neuroscience, Mental Health and Addiction, Canadian Institutes of Health Research (CIHR).

As a clinician, the driving force behind her research comes from the patient. Her work is oriented toward translational research and is funded mainly by CIHR and the Natural Sciences and Engineering Research Council of Canada. Her research has been focusing on the optimization of the functional outcome of corneal transplantation, based on leading edge progress in the fields of tissue engineering, femtosecond laser and biomaterials technologies.

Financial disclosure: Dr. Brunette does not have any affiliation (financial or otherwise) with a commercial organization.



Elementy, w których Dr. Isabelle Brunette, MD, FRCSC uczestniczy

piątek 1 czerwiec, 2018

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)

niedziela 16 czerwiec, 2019

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)

sobota 27 czerwiec, 2020

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
10:45
10:45 - 12:15 | 1 godz. 30 min.
Ocular Regenerative Medicine

sobota 11 czerwiec, 2022

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
12:30
12:30 - 14:00 | 1 godz. 30 min.
Ocular Regenerative Medicine

Learning ObjectivesAt the end of this session, participants will be able to:Define the signs and symptoms of Limbal Stem Cell DeficiencyDescribe the treatment modalities currently in use to treat Limbal Stem Cell DeficiencyDescribe how gene-based therapy is used to treat retinal diseaseDescribe how cell-based therapy is used to treat retinal diseaseCanMEDS Roles: Medical Expert, Professional

sobota 17 czerwiec, 2023

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
10:45
10:45 - 12:15 | 1 godz. 30 min.
Ocular Regenerative Medicine

 Learning ObjectivesAt the end of this session, participants will be able to:Describe how cultured corneal endothelial cells can be used to treat corneal endothelial failureDescribe how the corneal neurotinization procedure is performed and compare with other treatment modalities for treating neurotrophic corneal ulcersDescribe how cultivated oral mucosal epithelial transplantation can be used to treat patients with Stevens-...

16:30
16:32 - 16:35 | 3 min.

 Authors: Isabelle Brunette 1, Michèle Mabon1, Akram Rahal2, Isabelle Hardy1, Alex Camacho1, Lamia Ammarkhodja3, Nora Cherifi3, Jean Meunier4.  1Centre Universitaire d’Ophtalmologie de l’Université de Montréal à l’Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada, 2Division of Otolaryngolo...